We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
81 hedge funds and large institutions have $156M invested in ANI Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 30 increasing their positions, 19 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
117% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 12
58% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 19
32% more capital invested
Capital invested by funds: $118M → $156M (+$38M)
21% more funds holding
Funds holding: 67 → 81 (+14)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
81
Holders Change
+14
Holders Change %
+20.9%
% of All Funds
2.33%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
26
Increased
30
Reduced
19
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$7.39M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.31M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$4.29M |
| 4 |
Renaissance Technologies
New York
|
+$3.69M |
| 5 |
CCM
Consonance Capital Management
New York
|
+$3.26M |
Top Sellers
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$6.31M |
| 2 |
Millennium Management
New York
|
-$5.57M |
| 3 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$3.14M |
| 4 |
MOACM
Mutual of America Capital Management
New York
|
-$1.72M |
| 5 |
PA
Perceptive Advisors
New York
|
-$1.41M |
